Suitability of IS<i>6110</i>-RFLP and MIRU-VNTR for Differentiating Spoligotyped Drug-Resistant <i>Mycobacterium tuberculosis</i> Clinical Isolates from Sichuan in China

<table>Schematic overview of the typing scheme developed to differentiate <i>M. tuberculosis</i> clinical isolates.</table>

BioMed Research International

fig3

Figure 3

Figure 3: Suitability of IS<i>6110</i>-RFLP and MIRU-VNTR for Differentiating Spoligotyped Drug-Resistant <i>Mycobacterium tuberculosis</i> Clinical Isolates from Sichuan in China 

Figure 3 | Suitability of IS6110-RFLP and MIRU-VNTR for Differentiating Spoligotyped Drug-Resistant Mycobacterium tuberculosis Clinical Isolates from Sichuan in China 